These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 11825307)

  • 1. Review of botulinum toxin type A and its clinical applications in migraine headache.
    Silberstein SD
    Expert Opin Pharmacother; 2001 Oct; 2(10):1649-54. PubMed ID: 11825307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin type A (BOTOX) for treatment of migraine.
    Binder WJ; Brin MF; Blitzer A; Pogoda JM
    Dis Mon; 2002 May; 48(5):323-35. PubMed ID: 12195263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventative treatment for migraine and tension-type headaches : do drugs having effects on muscle spasm and tone have a role?
    Freitag FG
    CNS Drugs; 2003; 17(6):373-81. PubMed ID: 12696998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products.
    Dessy LA; Fallico N; Mazzocchi M; Scuderi N
    Am J Clin Dermatol; 2011 Dec; 12(6):377-88. PubMed ID: 21877763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A preliminary comparison of the efficacy and tolerability of botulinum toxin serotypes A and B in the treatment of myofascial pain syndrome: a retrospective, open-label chart review.
    Lang AM
    Clin Ther; 2003 Aug; 25(8):2268-78. PubMed ID: 14512133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased Pulmonary Function During Botulinum Toxin A Therapy for Chronic Migraines in a 17-Year-Old Female.
    Oliver JD; Boesch RP; Mack KJ
    Headache; 2018 Sep; 58(8):1259-1261. PubMed ID: 30033516
    [No Abstract]   [Full Text] [Related]  

  • 7. Botulinum neurotoxin for the treatment of migraine and other primary headache disorders: from bench to bedside.
    Dodick DW
    Headache; 2003; 43 Suppl 1():S25-33. PubMed ID: 12887391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of migraine headache with botulinum toxin type A.
    Binder WJ; Blitzer A
    Facial Plast Surg Clin North Am; 2003 Nov; 11(4):465-75. PubMed ID: 15062251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group.
    Silberstein S; Mathew N; Saper J; Jenkins S
    Headache; 2000 Jun; 40(6):445-50. PubMed ID: 10849039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based medicine: botulinum toxin A in migraine and tension-type headache.
    Göbel H; Heinze A; Heinze-Kuhn K; Jost WH
    J Neurol; 2001 Apr; 248 Suppl 1():34-8. PubMed ID: 11357239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin type A in prophylactic treatment of migraine.
    Anand KS; Prasad A; Singh MM; Sharma S; Bala K
    Am J Ther; 2006; 13(3):183-7. PubMed ID: 16772757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum neurotoxin for the treatment of migraine and other primary headache disorders.
    Blumenfeld AM; Dodick DW; Silberstein SD
    Dermatol Clin; 2004 Apr; 22(2):167-75. PubMed ID: 15222577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum Toxin Type a as a Therapeutic Agent against Headache and Related Disorders.
    Luvisetto S; Gazerani P; Cianchetti C; Pavone F
    Toxins (Basel); 2015 Sep; 7(9):3818-44. PubMed ID: 26404377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin type A for the treatment of migraine.
    Aurora S
    Expert Opin Pharmacother; 2006 Jun; 7(8):1085-95. PubMed ID: 16722818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type a for chronic migraine.
    Ashkenazi A
    Curr Neurol Neurosci Rep; 2010 Mar; 10(2):140-6. PubMed ID: 20425239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for antinociceptive activity of botulinum toxin type A in pain management.
    Aoki KR
    Headache; 2003; 43 Suppl 1():S9-15. PubMed ID: 12887389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A].
    Cardoso F
    Arq Neuropsiquiatr; 2003 Sep; 61(3A):607-10. PubMed ID: 14513166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metallic taste: an unusual reaction to botulinum toxin A.
    Murray C; Solish N
    Dermatol Surg; 2003 May; 29(5):562-3. PubMed ID: 12752530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights from 25 years of onabotulinumtoxinA in migraine - mechanisms and management.
    Pozo-Rosich P; Alpuente A; Silberstein SD; Burstein R
    Nat Rev Neurol; 2024 Sep; 20(9):555-568. PubMed ID: 39160284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin for chronic migraine.
    Med Lett Drugs Ther; 2011 Jan; 53(1356):7-8. PubMed ID: 21252842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.